Company Information

  

Address: 1550 E GUDE DR  
City: ROCKVILLE 
State: MD 
Zip Code: 20850 
Telephone: 301-838-2500 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Supernus Pharmaceuticals, Inc. (the Company) was incorporated in Delaware and commenced operations in 2005. The Company became publicly traded in 2012 and is listed on The Nasdaq Stock Exchange under the ticker symbol SUPN. Our principal executive offices are in Rockville, Maryland. We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 25 years: initially as a privately-held stand-alone development organization, then as a United States (U.S.) subsidiary of Shire Plc and, upon our acquisition of substantially all of the assets of Shire Laboratories Inc. in late 2005, as Supernus Pharmaceuticals. On October 4, 2018, we acquired Biscayne Neurotherapeutics, Inc. (Biscayne), a privately-held company developing a novel treatment for epilepsy.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/20191.94NA17.06
03/20191.90NA18.44
12/20182.05NA16.20
09/20181.83NA27.51
06/20181.62NA36.94
03/20181.38NA33.19
12/20171.08NA36.90
09/20171.10NA36.36

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2018 Leverage 2018
Net Inc/Comm Equity0.30Total Liab/Total Assets0.54
Net Inc/Total Assets0.11Total Liab/Inv Cap0.64
Net Inc/Inv Cap0.14Total Liab/Comm Equity1.42
Pretax Inc/Net Sales0.34Interest Coverage Ratio8.74
Net Inc/Net Sales0.27Curr Debt/EquityNA
Cash Flow/Net Sales0.32LTD/Equity0.73
SG&A/NetSales0.39Total Debt/Equity0.73
Asset Utilization   Liquidity  
Net Receivables Turnover4.85Quick Ratio2.90
Inventory Turnover0.73Current Ratio3.06
Inventory Day Sales0.00Net Rec/Curr Assets0.21
Net Sales/Work Cap1.23Inv/Curr Assets0.05
Net Sales/PP&E99.85  

Income Statement (Millions)

  6/30/2019 3/31/2019 12/31/2018 9/30/2018
Total Revenues(Net Sales) 104.70 85.47 115.93 103.00
Cost of Goods Sold 4.04 3.68 4.19 4.21
Selling & Admin Exps 41.08 40.97 42.05 40.89
Operating Income 42.60 25.43 39.86 37.48
Interest Exp NA NA 5.60 12.51
Pretax Income 42.75 24.24 38.77 36.37
Other Income 0.15 -1.19 4.51 11.41
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 32.73 18.34 25.89 28.01

Balance Sheet (Millions)

Assets 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Cash & Short Term Investments 258.57 292.94 356.02 280.23
Receivables - Total 84.56 79.95 102.92 77.75
Inventories - Total 26.02 26.52 25.66 23.28
Total Current Assets 390.91 419.97 493.49 390.56
Net Property, Plant & Equipment 23.67 24.28 4.10 6.93
Total Assets 1,063.68 1,025.45 977.81 922.51
Liabilities        
Accounts Payable 143.97 151.71 161.35 138.35
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 143.97 151.71 161.35 138.35
Long-Term Debt 337.21 333.31 329.46 325.67
Total Liabilities 540.77 545.43 524.79 500.58
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.05 0.05 0.05 0.05
Retained Earnings 137.56 104.83 86.49 60.60
Treasury Stock NA NA NA NA
Total Stockholders' Equity 522.90 480.02 453.02 421.94
Total Liabilities and Stockholders' Equity 1,063.68 1,025.45 977.81 922.51

Cash Flow Summary (Millions)

Categories 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Net Cash Provided by Operating Activities 28.69 32.99 32.85 62.45
Net Cash Provided by Investing Activities -65.76 -103.25 34.33 25.34
Net Cash Provided by Financing Activities 1.64 0.78 1.25 0.83

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201492.68-10.920.32
12/2015147.4613.940.28
12/2016215.0091.221.76
12/2017302.2457.281.08
12/2018408.90110.992.05
Growth Rates44.93--59.09

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/1932153,174--




Report Date : 9/10/2019

Powered By Edgar Online © 2019EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.